(S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002230:Carbidopa / Q000494:pharmacology; D002396:Catechols / Q000494:pharmacology; D003653:Decarboxylation; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D007668:Kidney / Q000201:enzymology; D008297:Male; D051379:Mice; D009206:Myocardium / Q000032:analysis / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D012694:Serine / Q000494:pharmacology*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D014439:Tyramine / Q000494:pharmacology
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D002396:Catechols; D012694:Serine; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D004296:Dopa Decarboxylase; D002230:Carbidopa; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine